[Other] Nivolumab Plus Ipilimumab in Patients With Solid Tumors With ATM Mutations: Results From the Targeted Agent and Profiling Utilization Registry (TAPUR) Study

tarekcnn Post time 1 hour(s) ago | Show all posts |Read mode
This post will be closed automatically in 2026-07-27 16:53
Reward20points

journalㄩJCO Precision Oncology

AuthorsㄩNitin Rohatgi; Michael Rothe; Pam K. Mangat; Elizabeth Garrett-Mayer; Funda Meric-Bernstam; Evan Pisick; Olatunji B. Alese; Christopher M. Reynolds; Ramya Thota; Gina M. Vaccaro; Margaret von Mehren; Rebecca C. Arend; Vi K. Chiu; Herbert L. Duvivier; Philip J. Gold; Keely Hack; Alissa S. Marr; Arthur Winer; Gina N. Grantham; Dominique C. Hinshaw; Abigail Gregory; Susan Halabi; Richard L. Schilsky

Published dateㄩ2023-9-

DOIㄩ10.1200/po.23.00279

PDF linkㄩhttps://ascopubs.org/doi/pdfdirect/10.1200/PO.23.00279

Article linkㄩhttps://doi.org/10.1200/po.23.00279

Article SourceㄩAmerican Society of Clinical Oncology (ASCO)


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Intermediate member
  • post

  • reply

  • points

    390


Return to the list